Hamster Greene melanoma in the rabbit eye: immunosuppressive treatment to improve this tumor model
- PMID: 7843595
- DOI: 10.1007/BF00171385
Hamster Greene melanoma in the rabbit eye: immunosuppressive treatment to improve this tumor model
Abstract
Background: The hamster Greene melanoma (HGM) implanted in the anterior chamber of the rabbit eye has been used to study experimental therapies for human uveal melanoma. However, the occurrence of spontaneous necrosis limits the value of this model for long-term evaluation of experimental treatments. In the present study we tested the hypothesis that an immune response is the cause of this necrosis and that prevention of the immune response can prolong the experimentation time
Methods: HGM was implanted in the anterior chamber of control, presensitized and immunosuppressed rabbits. The effects of sensitization and immunosuppression were assessed by clinical and histological observation
Results: Sensitization led to a significant slowing down of tumor growth, but not to a difference in necrosis. Immunosuppressive treatment with cyclosporin A improved the success rate of implantation and decreased the amount of necrosis in the tumor
Conclusion: The immune response plays a role in the occurrence of necrosis. However, although immunosuppressive treatment with cyclosporin A decreased the amount of necrosis, significant necrosis still occurred, suggesting that other factors like angiogenesis play a part as well and still limit the usefulness of this model in the long-term evaluation of experimental therapies.
Similar articles
-
Hamster Greene melanoma implanted in the anterior chamber of a rabbit eye: a reliable tumor model?Ophthalmic Res. 1992;24(2):119-24. doi: 10.1159/000267156. Ophthalmic Res. 1992. PMID: 1608597
-
Immunohistochemical characterization of experimental Greene melanoma.Ophthalmic Res. 1992;24(1):55-8. doi: 10.1159/000267146. Ophthalmic Res. 1992. PMID: 1608593
-
Methods for subchoroidal implantation of Greene melanoma in rabbits.Int J Clin Oncol. 2004 Apr;9(2):79-84. doi: 10.1007/s10147-004-0384-6. Int J Clin Oncol. 2004. PMID: 15108038 Review.
-
Bacteriochlorin a, a new photosensitizer in photodynamic therapy. In vivo results.Invest Ophthalmol Vis Sci. 1990 Aug;31(8):1444-50. Invest Ophthalmol Vis Sci. 1990. PMID: 2387678
-
Animal models for the study of uveal melanoma.Int Ophthalmol Clin. 1980 Summer;20(2):143-60. Int Ophthalmol Clin. 1980. PMID: 6995384 Review. No abstract available.
Cited by
-
Animal Models of Uveal Melanoma.Ann Eye Sci. 2022 Mar;7:7. doi: 10.21037/aes-21-30. Epub 2022 Mar 15. Ann Eye Sci. 2022. PMID: 35350473 Free PMC article.
-
Animal Eye Models for Uveal Melanoma.Ocul Oncol Pathol. 2015 Apr;1(3):141-50. doi: 10.1159/000370152. Epub 2015 Apr 9. Ocul Oncol Pathol. 2015. PMID: 27172424 Free PMC article. Review.
-
The Anterior Eye Chamber as a Visible Medium for In Vivo Tumorigenicity Tests.Stem Cells Transl Med. 2022 Aug 23;11(8):841-849. doi: 10.1093/stcltm/szac036. Stem Cells Transl Med. 2022. PMID: 35666752 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Medical